Geeta Shroff

Learn More
Cellphones have the potential to improve education for the millions of underprivileged users in the developing world. However, mobile learning in developing countries remains under-studied. In this paper, we argue that cellphones are a perfect vehicle for making educational opportunities accessible to rural children in places and times that are more(More)
Background: The present study evaluated the efficacy and safety of human embryonic stem cell (hESC) therapy in patients with CP. Materials and methods: This analysis included patients (30 days-18 yr) with documented diagnosis of CP. The study consisted of four treatment phases (T1, T2, T3, T4) separated by gap phases. Efficacy of hESC therapy was evaluated(More)
Article History: Received 14, March, 2015 Received in revised form 23, March, 2015 Accepted 13, April, 2015 Published online 28, April, 2015 Regeneration of damaged neurons in neurodegenerative disorders like cerebral palsy and spinal cord injury is a major challenge. The possibility of replacing the non-functional neurons remains an attractive but an(More)
Background: Use of human embryonic stem cells (hESCs) has been explored for treatment of cortical visual impairment (CVI) in children with cerebral palsy (CP). Objectives: The study evaluated efficacy and safety of hESC therapy in 40 CP children with CVI. Methods: The study had four treatment phases (T1, T2, T3, and T4) separated by gap phases. Patients(More)
Introduction: Friedreich’s ataxia (FRDA) is an autosomal recessive inherited disease that damages nervous system and impairs muscle coordination. FRDA usually begins in childhood and is caused by expanded GAA triplet repeat within the first intron of the frataxin (FXN) gene leading to reduced level of mitochondrial protein frataxin. There is no effective(More)
BACKGROUND Human embryonic stem cells (hESCs) are pluripotent cells that have the potential to self-renew and differentiate into all types of human cells. PURPOSE The present study was aimed at establishing the safety of hESC therapy in patients with terminal/incurable conditions. METHODS This was a single cohort study conducted at Nutech Mediworld, New(More)